Briefs: Kilitch Drugs India, Family Care Hospitals and Krishna Institute of Medical Sciences
News

Briefs: Kilitch Drugs India, Family Care Hospitals and Krishna Institute of Medical Sciences

Krishna Institute of Medical Sciences to consider raising Rs. 300 crores

  • By IPP Bureau | January 01, 2023

Kilitch Drugs India

Kilitch Drugs (India) Limited has made additional investment of USD 2,68,000 to acquire equity shares of Kilitch Estro Biotech PLC, foreign subsidiary of the Company to meet working capital requirement of the Company.

Family Care Hospitals

The Rights Issue Committee of the Board of directors of Family Care Hospitals Limited has considered and approved the terms of the Rights Issue. Rights Issue size: up to 4,07,67,000 fully paid-up Equity Shares having face value of Rs. 10/- each at an issue price of Rs. 12/- per Equity Share (including a premium of Rs. 2 per Equity Share) aggregating up to Rs. 48.92 crore.

Krishna Institute of Medical Sciences

A meeting of the Board of Directors of Krishna Institute of Medical Sciences Limited is scheduled to be held on Wednesday, January 4, 2023, to consider and approve raising of funds by way of issuance of Non-Convertible Debentures (NCDs), aggregating to Rs. 300 crores in one or more tranches over a period of time.

Upcoming E-conference

Other Related stories

Startup

Digitization